Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Gene found in mice may play role in determining susceptibility to tuberculosis in humans

07.04.2005


Gene is found in the chromosomal region that influences innate immunity to tuberculosis



Researchers from the Harvard School of Public Health studying tuberculosis resistance and susceptibility in animals have identified a gene in mice which plays a significant role in limiting the multiplication of intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes inside host cells. The gene, Intracellular pathogen resistance 1 (Ipr1), found in the chromosome location known as sst1 (super susceptibility to tuberculosis 1), turns on a regulated cell death pathway of the bacteria-infected cells causing apoptosis and prevents catastrophic cell death, or necrosis. The findings appear in a paper in the April 7, 2005 issue of the journal Nature.

It is estimated that 8 million people are infected with tuberculosis annually with approximately 2 million of those dying from the lung disease per year. Yet only about 10 percent of people infected actually develop tuberculosis. Stress, malnutrition and other environmental factors significantly influence an individuals’ susceptibility to developing the disease. In addition, genetic factors have been known to play an important role in determining outcomes of tuberculosis infection in human and other mammalian hosts. However, individual host resistance genes such as Ipr1, involved in innate immunity for tuberculosis, have been difficult to pinpoint, because of a highly complex multigenic control of host immunity.


The researchers studied which genes might influence an individuals’ susceptibility to developing tuberculosis and found that an important genetic determinant of host resistance to tuberculosis is encoded within the region on mouse chromosome 1, which they named sst1. By identifying the Ipr1 gene within the sst1 region they believe they have uncovered a new mechanism that helps in limiting the possibility of developing M. tuberculosis, especially in the lungs.

Of interest, the Ipr1 gene also controls innate immunity to another intracellular pathogen Listeria monocytogenes, a parasitic disease transferred to humans generally from consuming infected animal products and that causes flu-like symptoms, swelling of the brain and for pregnant women potential loss of fetus. That suggests that the Ipr1 gene controls a general mechanism that protects against other intracellular pathogens besides M. tuberculosis. The researchers suggest that the human equivalent of Ipr1 might be a gene described as SP110 and may play a significant role in determining tuberculosis susceptibility in people.

Igor Kramnik, assistant professor of immunology and infectious disease at the Harvard School of Public Health and senior author of the study said, "The findings are encouraging and highlight the role of genetic function in determining whether a person has a high risk of developing tuberculosis. Finding a specific gene in a mouse that has a human equivalent within a highly conserved genetic region suggests that the human equivalent may also be involved in innate immunity to the disease and may further lead to development of diagnostic tests and prevention approaches." He added, "Further studies of the Ipr1 gene in a mouse model and its counterpart in humans will improve our understanding of how our immune system works during complex interactions with live, and very successful, pathogens."

Kevin C. Myron | EurekAlert!
Further information:
http://www.hsph.harvard.edu

More articles from Life Sciences:

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Will Earth still exist 5 billion years from now?

08.12.2016 | Physics and Astronomy

Oxygen can wake up dormant bacteria for antibiotic attacks

08.12.2016 | Health and Medicine

Newly discovered bacteria-binding protein in the intestine

08.12.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>